FDA Grants Full Approval to Pfizer-BioNTech COVID-19 Vaccine August 23, 2021 By Carl O'Donnell and Manas Mishra The U.S. drug regulator on Monday granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine, making it the first...
Pfizer-BioNTech Seek FDA Full Approval for Authorized COVID-19 Vaccine May 7, 2021 By Ankur Banerjee Pfizer Inc. and German partner BioNTech SA said on Friday they have started an application process with the U.S. Food...
U.S. Recommends Pausing Use of J&J COVID Vaccine over Rare Blood Clots April 13, 2021 By Manas Mishra and Michael Erman U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson’s COVID-19 vaccine for at least a few...
Can Insurance-Related Firms Compel Employees to Get COVID-19 Vaccination? December 28, 2020 By Bryan Johnson and Samuel Licker The long-awaited and highly anticipated COVID-19 vaccine is here. The first to arrive on the scene, from Pfizer-BioNTech, received emergency...
Pfizer Vaccine Faces Some Storage, Production, Snowstorm Challenges December 16, 2020 By Rebecca Spalding and Carl O'Donnell The first days of Pfizer Inc.’s COVID-19 vaccine rollout have seen unexpected hitches including some vaccines being stored at excessively...
FDA Appears Close to Approving ‘Highly Effective’ Moderna COVID-19 Vaccine December 15, 2020 By Manas Mishra and Michael Erman Moderna Inc.’s COVID-19 vaccine appeared to be set for regulatory authorization this week after U.S. Food and Drug Administration staff...
FDA Expected to Quickly Approve Pfizer’s COVID Vaccine December 11, 2020 The U.S. Food and Drug Administration said on Friday it was working rapidly to issue an emergency use authorization for...
World Encouraged by Moderna, Pfizer Vaccines’ Success in Trials November 16, 2020 By Julie Steenhuysen and Michael Erman Moderna Inc.’s experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company...